Dashboard
Strong Long Term Fundamental Strength with a 26.76% CAGR growth in Operating Profits
Healthy long term growth as Net Sales has grown by an annual rate of 176.51% and Operating profit at 26.76%
With a growth in Net Sales of 260.74%, the company declared Very Positive results in Sep 25
With ROE of 10.4, it has a Very Attractive valuation with a 0.9 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0% of the company
Below par performance in long term as well as near term
Stock DNA
Holding Company
INR 1,041 Cr (Micro Cap)
8.00
23
0.00%
0.62
10.36%
0.88
Total Returns (Price + Dividend) 
Abans Financial for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Abans Financial Sees Revision in Market Evaluation Amid Mixed Performance
Abans Financial has experienced a revision in its market evaluation, reflecting a nuanced shift in its assessment across key financial and technical parameters. This change comes amid a backdrop of strong fundamental growth yet subdued stock returns, highlighting the complexities investors face when analysing microcap holding companies.
Read More
Abans Financial Services: Technical Momentum Shifts Amid Market Challenges
Abans Financial Services has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and investor sentiment. Recent assessment changes reveal a transition in key technical indicators, signalling a nuanced outlook for this holding company amid broader market fluctuations.
Read More
Abans Financial Services Faces Bearish Momentum Amid Technical Shifts
Abans Financial Services is currently exhibiting a shift in price momentum, with technical indicators signalling a predominantly bearish outlook across multiple timeframes. Recent evaluation adjustments highlight a transition from mildly bearish to bearish trends, reflecting challenges in the stock’s near-term performance despite some mixed signals from momentum oscillators.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
28-Nov-2025 | Source : BSEAllotment of Equity Shares pursuant to Abans Financial Services Limited ESOP Scheme 2023
Intimation Pursuant To Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015
13-Nov-2025 | Source : BSE1) Resignation of Statutory Auditors of Material Subsidiary of the Company. 2) Appointment of Statutory Auditors of Material Subsidiary of the Company.
Announcement under Regulation 30 (LODR)-Newspaper Publication
13-Nov-2025 | Source : BSENewspaper Advertisement regarding Unaudited Financial Results for quarter and half year ended September 30 2025
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
10.3734
Held by 0 Schemes
Held by 20 FIIs (16.15%)
Abhishek Pradeepkumar Bansal (70.54%)
Resonance Opportunities Fund (4.89%)
5.98%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 260.74% vs 78.13% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 27.51% vs 5.64% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 830.84% vs 51.01% in Sep 2024
Growth in half year ended Sep 2025 is 43.09% vs 17.23% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 96.77% vs 93.89% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 18.13% vs 42.23% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 137.75% vs 18.70% in Mar 2024
YoY Growth in year ended Mar 2025 is 24.65% vs 26.21% in Mar 2024






